PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Melamine

EC / List no: 203-615-4 CAS no: 108-78-1
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Targeted
Status
Concluded
Decision date
Decision
Latest update
26-Nov-2022
Additional information
ECHA has performed an assessment and did not issue a decision.
More information View
DEv 2
Scope
Testing Proposal
Status
Concluded
Decision date
22-Nov-2017
Decision
Latest update
26-Nov-2022
Additional information
More information View
DEv 3
Scope
Targeted
Status
Concluded
Decision date
Decision
Latest update
26-Nov-2022
Additional information
ECHA has performed an assessment and did not issue a decision.
More information View
DEv 4
Scope
Comprehensive
Status
Concluded
Decision date
Decision
Latest update
26-Nov-2022
Additional information
ECHA has performed an assessment and did not issue a decision.
More information View
DEv 5
Scope
Targeted
Status
Concluded
Decision date
Decision
Latest update
26-Nov-2022
Additional information
ECHA has performed an assessment and did not issue a decision.
More information View
DEv 6
Scope
Targeted
Status
Concluded
Decision date
17-Dec-2013
Decision
Latest update
26-Nov-2022
Additional information
More information View
PBT - Persistent, bioaccumulative and toxic assessment
PBT 1
Authority
Germany
Status
Under development
Outcome
Under development
Hazard assessment outcome document
Remarks
Concern
Date of intention
01-Sep-2021
Date of hazard assessment
Latest update
30-Sep-2021
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
France
Status
Under development
Outcome
Under development (other)
Hazard assessment outcome document
Remarks
Concern
Endocrine disruption
Date of intention
08-Feb-2022
Date of hazard assessment
Latest update
10-Feb-2022
More information View
Regulatory risk management
CLH - Harmonised classification and labelling
CLH 1
Status
Opinion Adopted
Date of intention
15-Aug-2017
Withdrawal date
Submitter
Germany
Proposed harmonised classification by the dossier submitter
Carc. 2, H351
STOT RE 1, H372
Remarks
Date of opinion
10-Dec-2020
RAC Opinion
Latest update
28-Apr-2023
More information View
SVHC - Substances of very high concern
SVHC 1
Status
Identified SVHC
Date of intention
21-Jun-2022
Withdrawal date
Submitter
Germany
Remarks
Scope
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)
Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment)
Date of inclusion in Candidate List
17-Jan-2023
Latest update
23-May-2023
More information View
Assessment of regulatory needs
ARN 1
Authority
Germany
Concern
Bioaccumulation
Carcinogenic
Persistence
STOT RE
Toxic for reproduction
Status
Concluded
Follow-up
CLH
SVHC
Other legislation
Foreseen regulatory need
Summary document
Group name
Remarks
PMT properties (Art. 57 f) under consideration
Date of intention
27-May-2021
Date of assessment
14-Jun-2022
Latest update
03-Apr-2023
More information View

List entry date: 28-Feb-2018

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.